Abstract
A series of N-benzyl-N-hydroxy-3-(cyclopentyloxy)-4-methoxybenzene carboxamide analogues have been investigated as PDE4 inhibitors. Two compounds, 3- carboxylic (12b) and 3-hydroxamic acid (13b) derivatives, have shown potent inhibition toward PDE4, with IC50s of 0.114 and 0.047 μM, respectively. Docking of the compound 13b into the binding pocket of the PDE4 catalytic domain revealed interactions corresponding to those of the cAMP substrate.
Keywords: cyclopentyloxy, methoxybenzene, N-benzyl-N-hydroxy, 3-hydroxamic acid
Letters in Drug Design & Discovery
Title: SAR and Molecular Modeling of N-Benzyl-N-hydroxy-3-(cyclopentyloxy)-4- methoxybenzene Carboxamide Analogues as Potent Phosphodiesterase-4 Inhibitors
Volume: 1 Issue: 1
Author(s): Jeewoo Lee, Su Yeon Kim, Hye Ra Lee and Je Hak Kim
Affiliation:
Keywords: cyclopentyloxy, methoxybenzene, N-benzyl-N-hydroxy, 3-hydroxamic acid
Abstract: A series of N-benzyl-N-hydroxy-3-(cyclopentyloxy)-4-methoxybenzene carboxamide analogues have been investigated as PDE4 inhibitors. Two compounds, 3- carboxylic (12b) and 3-hydroxamic acid (13b) derivatives, have shown potent inhibition toward PDE4, with IC50s of 0.114 and 0.047 μM, respectively. Docking of the compound 13b into the binding pocket of the PDE4 catalytic domain revealed interactions corresponding to those of the cAMP substrate.
Export Options
About this article
Cite this article as:
Lee Jeewoo, Kim Yeon Su, Lee Ra Hye and Kim Hak Je, SAR and Molecular Modeling of N-Benzyl-N-hydroxy-3-(cyclopentyloxy)-4- methoxybenzene Carboxamide Analogues as Potent Phosphodiesterase-4 Inhibitors, Letters in Drug Design & Discovery 2004; 1 (1) . https://dx.doi.org/10.2174/1570180043485662
DOI https://dx.doi.org/10.2174/1570180043485662 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phage Display Derived Therapeutic Antibodies
Current Pharmaceutical Biotechnology Methotrexate Hepatotoxicity in Rheumatoid Arthritis: An Analysis of the Physicians’ Policy
Current Rheumatology Reviews Response to Rituximab: Has the Original Hypothesis Been Confirmed?
Current Pharmaceutical Design Recognizing Severe Adverse Drug Reactions: Two Case Reports After Switching Therapies to the Same Generic Company
Current Drug Safety Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Current Pharmaceutical Design Editorial [Hot Topic: Spondyloarthritis in Asia Guest Editor: Chung-Tei Chou]
Current Rheumatology Reviews The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Current Aging Science The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
Current Medicinal Chemistry Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis
Current Pharmaceutical Biotechnology Extra Virgin Olive Oils Polyphenols: Biological Activities
Current Pharmaceutical Design Advances in Encoding of Colloids for Combinatorial Libraries: Applications in Genomics, Proteomics and Drug Discovery
Current Pharmaceutical Biotechnology A Review on Extraction, Synthesis and Anticancer Activity of Betulinic Acid
Current Bioactive Compounds Editorial
Recent Patents on Inflammation & Allergy Drug Discovery Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis
Current Pharmaceutical Design Management of Painful Symptoms with Duloxetine: A Review of the Efficacy in Pre-Clinical and Clinical Studies
Current Drug Therapy Effect of Alpha-1-Acid Glycoprotein Binding on Pharmacokinetics and Pharmacodynamics
Current Drug Metabolism Drug Targets in Infections with Ebola and Marburg Viruses
Infectious Disorders - Drug Targets Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets CD248: Reviewing its Role in Health and Disease
Current Drug Targets